Table2.
Cancer | Molecule | Mechanism | Function | References |
---|---|---|---|---|
HCC | miR-125 | – | promoting invasion | 81 |
miR-142, miR-223 | – | inhibiting proliferation | 89 | |
PDAC | miR-501-3p | inhibiting TGFBR3, activating TGF-β signal | promoting invasion | 83 |
miR-365 | – | inducing resistance against gemcitabine | 90 | |
Colon cancer | miR-21, miR-155 | downregulating BRG1 | promoting metastasis | 86 |
Breast cancer | miR-233 | Mef2c/β-catenin | promoting invasion | 88 |
IL-6 | STAT3 pathway | promoting proliferation and metastasis | 91 | |
ADAM15 | inhibiting avβ3 | inhibiting adhesion, growth and migration | 92 | |
Recipient gastric cancer | ApoE | PI3K/AKT | promoting migration | 93 |
miR-21 | – | inducing resistance against DDP | 94 | |
Glioblastoma | miR-21 | targeting PDCD4 | inducing resistance against temozolomide | 95 |
modulating PEG3 | inducing immune evasion | 96 | ||
EOC | miR-223 | PTEN-PI3K/AKT | inducing chemotherapy resistance | 78 |
miR-29a-3p, miR-21-5p | upregulating Treg/Th17 ratio | inducing immune evasion | 97 |
–, unknown